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Abstract
Background: Data are available on short- and intermediate-term mortality rates after discharge for acutely
decompensated heart failure (ADHF). However, few studies specifically addressed ADHF outcomes in patients aged
75 years or over, who contribute more than half of all ADHF admissions. Our objectives here were to estimate the
long-term mortality of patients aged 75 years or over who were discharged after admission for ADHF and to
identify factors, especially geriatric findings, independently associated with 2-year mortality.
Methods: This prospective cohort study in five French hospitals included consecutive patients aged 75 years or
older and discharged after emergency-department admission for ADHF meeting Framingham criteria (N = 478;
median age, 85 years; 68% female). Kaplan-Meier 1-year and 2-year survival curves were plotted. Admission
characteristics independently associated with overall 2-year mortality were identified using multivariable Cox
proportional-hazards regression.
Results: Mortality was 41.7% (95% confidence interval [95% CI], 37.2%–53.5%) after 1 year and 56.0% (95% CI, 51.
5%–60.7%) after 2 years. By multivariable analysis, independent predictors of 2-year mortality were male sex
(hazard ratio [HR], 1.36; 95% CI, 1.00–1.82), age >85 years (HR, 1.57; 95% CI, 1.19–2.07), higher number of impaired
activities of daily living (HR, 1.11 per impaired item; 95% CI, 1.05–1.17), recent weight loss (HR, 1.61; 95% CI, 1.14–
2.28), and lower systolic blood pressure (HR, 0.86 per standard deviation increase; 95% CI, 0.74–0.99). Creatinine
clearance ≤30 mL/min showed a trend toward an association with 2-year mortality (HR, 1.36; 95% CI, 0.97–2.00).
Conclusion: Functional impairment before admission is associated with higher long-term mortality in patients ≥75 years
admitted for ADHF. This study focused on geriatric markers not traditionally collected in heart-failure patients but did not
analyse all cardiologic parameters associated with outcomes in other studies. Nevertheless, our findings may contribute to
identify those patients admitted for ADHF who have the worst prognosis.
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Background
Heart failure (HF) affects more than 15 million people
in Europe, many of whom are elderly [1]. The heavy
burden of morbidity and mortality associated with HF is
comparable to that of many advanced malignancies [2].
The mean life expectancy of patients discharged after
admission for HF has been estimated at 5.5 years [3].
Several studies investigated the short- and intermediate-
term risk of death after discharge for acutely decompen-
sated heart failure (ADHF). In patients aged 65 years or
more, overall mortality ranged from 25% to 40%
after 1 year [4–15] and from 22% to 52.9% after
2 years [16–18]. However, few studies specifically ad-
dressed ADHF outcomes in patients aged 75 years
or over [9, 10], who contribute more than half of all
patients admitted for ADHF [19]. Moreover, only
two of these studies reported the associations linking
geriatric syndromes to 1-year mortality in elderly pa-
tients with HF [6, 16], and none investigated clinical
and laboratory variables concomitantly with geriatric
findings. These knowledge gaps need to be filled, as
the prevalence of chronic diseases increases with
age, so that most patients older than 75 years have
multiple co-morbidities [20]. We previously reported
co-morbidities and functional impairments independ-
ently associated with in-hospital mortality of older
patients admitted for ADHF (ELISA survey) [21]. Better
knowledge of risk factors for long-term mortality may
help to define follow-up and management goals and may
improve treatment decision-making.
Here, our primary objective was to assess the long-
term survival of patients aged 75 years or over and
discharged after in-patient treatment of ADHF. We
also aimed to identify factors, especially geriatric find-
ings, independently associated with 2-year mortality.
To achieve these objectives, we used data from the
previously described ELISA cohort study of severe
heart failure designed to identify patients with the




ELISA is a prospective longitudinal cohort study of 680
older patients with ADHF seen at the emergency depart-
ments of five French hospitals [21], between October
2004 and December 2007. The ELISA cohort was
established in compliance with good clinical practice
guidelines and was approved by the appropriate ethics
committee (institutional review board of the Henri-
Mondor Teaching Hospital, Créteil, France). Cohort
participants or their relatives gave their written informed
consent for the collection of personal data to be used in
further analyses. The present report complies with the
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement [22].
We estimated 1-year and 2-year mortality rates and we
looked for associations linking admission characteristics,
including geriatric findings and co-morbidities, to 2-year
mortality among hospital survivors.
Patients
As previously described [21], consecutive patients aged
75 years or older and admitted to an emergency depart-
ment with a diagnosis of ADHF during a 1-year study
period were included in the ELISA cohort if they met
Framingham criteria for HF (at least two major criteria
or one major criterion plus two minor criteria) [23];
dyspnoea at rest or with minimal exertion; and an
expected hospital stay duration ≥24 h. Exclusion cri-
teria were ventricular arrhythmia at admission and
transfer to another hospital after the initial evaluation.
For the present study focusing on survival after hos-
pital discharge, we excluded the patients who died in
the hospital.
Data collection
Included patients underwent a standardised clinical
evaluation at the emergency department. However, some
parameters such as the get-up-and-go test were collected
as early as possible after the relief of ADHF symptoms.
Baseline data included socio-demographic characteristics,
medical history, clinical characteristics, and laboratory test
results. Trained clinical research assistants recorded geri-
atric parameters using validated tools. Nutritional status
was assessed using the Mini Nutritional Assessment-Short
Form [24] to classify patients into three nutritional risk
categories (≥12, well-nourished; 8-11, at risk; and <8, mal-
nourished) [25]. Weight loss over the last three months
(none, 1 to 3 kg, or >3 kg) was recorded from the patients
or relatives then validated by medical record review. For
cognitive status, assessed using the MMSE, the cut-off of
17 indicating severe cognitive impairment was chosen
[26–28]. Mood was assessed using the 15-item Geriatric
Depression Scale (GDS), with scores ≥5 indicating a risk
of depression [29, 30]. Functional status was assessed
using the Katz activities of daily living scale (ADL) with
six items (bathing, dressing, toileting, transferring, contin-
ence, and feeding) scored from 2 (able to perform the
activity) to 0 (unable to perform the activity) [31]. The
number of impaired ADL items was recorded, as well as
the presence of functional impairment defined as a need
for assistance for at least one ADL (i.e., ADL score <12).
Impaired mobility was defined as a get-up-and-go test
time >20 s or an inability to perform the test [32]. Glom-
erular filtration rate was calculated using the abbreviated
Modification of Diet in Renal Disease.
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Follow-up after hospital discharge
Patients were monitored by telephone calls at three-
month intervals for 2 years after discharge or until death.
Vital status was collected from the next of kin, usual phys-
ician, or patient’s residential institution. The primary out-
come for the present analysis was overall 2-year mortality
after discharge.
Statistical analysis
Sample size was estimated for the main objective of
the ELISA cohort, namely, the identification of factors
associated with in-hospital mortality [21].
All tests were two-sided, and P values ≤0.05 were
considered significant. Analyses were performed using
STATA software version 12.0 (StataCorp, College
Station, TX, USA). No imputation for missing data was
performed.
Quantitative data are described as mean ± SD or me-
dian [25th-75th centiles], as appropriate, and categorical
variables as n (%). Overall survival was assessed from
discharge to death from any cause, 2 years after hospital
discharge or last follow-up for censored patients. We
used the non-parametric Kaplan-Meier method to esti-
mate 1-year and 2-year survival rates with their 95%
confidence intervals (95% CIs).
Characteristics of survivors and non-survivors were
compared using Cox proportional hazards regression
models with estimation of hazard ratios (HRs) and
their 95% CIs. Log-linearity was tested for quantitative
variables. Analyses were routinely adjusted for age dichot-
omised based on the median value (>85 versus ≤85 years).
Variables associated with P values <0.15 were selected for
multivariable analyses. Confounders and interactions
were tested in bivariate models. We also investigated a
potential centre effect. To avoid introducing corre-
lated variables into multivariable models, correlations
were assessed using Cramer’s V for categorical vari-
ables [33] and Spearman’s non-parametric rank correl-
ation (Rho) [34] for quantitative variables; values
above 0.50 were considered to indicate correlations.
The most relevant variables were identified based on
clinical relevance, number of missing values, and the
Akaike information criterion (AIC) [35, 36]. The pro-
portional hazards assumption was assessed both
graphically and statistically using the Schoenfeld resid-
uals test. This assumption was met for all variables in
the final models. Calibration and discrimination of the
final multivariable model were assessed using the
Gronnesby-Borgan goodness-of-fit test and Harrell’s c-
index, respectively [37, 38]. Model robustness was
tested using a non-parametric bootstrap resampling
procedure. The final Cox model was refit for the 500
bootstrap samples thus created [39].
Results
Among the 680 patients initially assessed for eligibility,
478 were analysed (Fig. 1). Table 1 reports their baseline
characteristics. Median age was 85 years (range, 75-105
years). Most patients (91%) had one or more cardiovas-
cular co-morbidities (myocardial infarction, stroke,
hypertension, and/or arrhythmia). More than half of pa-
tients had abnormal nutritional status, function, and/or
mobility. Polypharmacy was the rule (median, 7 drugs).
The 36 (7.5%) patients lost to follow-up were cen-
sored at the date of last information. Median follow-up
was 14.1 months (449 days [132–718 days]; range, 1–
770 days). Mortality was 41.7% (95% CI, 37.2%–53.5%)
after 1 year and 56.0% (95% CI, 51.5%–60.7%) after
2 years (Fig. 2). Median overall survival was 19 months
(1.6 years). Most deaths occurred early after hospital
discharge, after a median of about 6 months (184 days
[68–367 days]).
Factors associated with 2-year survival
By univariate analysis (Table 2), factors significantly as-
sociated with mortality were older age (Fig. 3); male sex;
anaemia; lower systolic blood pressure; renal failure;
lower body mass index, malnutrition, and recent weight
loss; and impairments in functional status and mobility.
Trends (P < 0.15) were observed for history of myocardial
infarction and severe cognitive impairment. Therefore,
these variables were potential candidates for multivariable
analysis. Neither other cardiovascular co-morbidities
nor polypharmacy were associated with 2-year mortal-
ity. No centre effect or effect modification by centre
was demonstrated.
Age, sex, creatinine clearance, anaemia, systolic blood
pressure, myocardial infarction, weight loss, body mass
index, MNA-SF score, ADL score, Timed Get-Up-and-
Fig. 1 Participant flow chart
Natella et al. BMC Geriatrics  (2017) 17:34 Page 3 of 10
Go score, and MMSE score were available for the multi-
variable Cox model. Mobility impairment, lower body
mass index, and MNA-SF category were not introduced
into multivariable models, as they correlated with func-
tional impairment and recent weight loss, respectively
(correlation index >0.5, P < 0.05). Because of their as-
sociation with other parameters, anaemia, myocardial
infarction, and cognitive impairment were not inde-
pendently associated with death in the multivariable
model (P > 0.15). No significant interactions were
found between variables associated with 2-year mor-
tality. By multivariable analysis (Table 3), five factors
were independently associated with 2-year mortality,
namely, male sex, age older than 85 years, higher
number of impaired ADL items, recent weight loss,
and lower systolic blood pressure. A trend was noted
for renal failure. The final model had good calibration (P
value of the goodness-of-fit test >0.20) and acceptable dis-
crimination (Harrell’s c-index, 0.64). The HRs estimated
after bootstrap resampling were close to those of the ori-
ginal model, suggesting excellent internal validity. All five
factors were also independently associated with 1-year
mortality (Additional file 1: Table S1).
Discussion
High 1-year and 2-year mortality rates of 41.7% and
56.0%, respectively, were documented in unselected eld-
erly patients discharged alive after treatment for ADHF.
Independent risk factors for death within 2 years were
older age, male sex, prior functional impairment, low
Table 1 Baseline characteristics of elderly patients admitted for




Age >85 years 222 (46)
Male sex 155 (32.4)
Living arrangements (n = 220/244)
Lives alone 386 (83.2)
Institutionalised (16.8)
Current or former smoker (n = 211/242) 110 (24.3)
Medical status
Co-morbidities (past or current):
Arteritis (n = 207/234) 53 (12.0)
Myocardial infarction (n = 220/251) 97 (20.6)
Stroke (n = 218/245) 51 (11.0)
Anaemia (n = 209/233) 116 (26.2)
Hypertensiona (n = 223/254) 354 (74.2)
Cardiac arrhythmia (n = 215/245) 313 (68.0)
Diabetes (n = 218/253) 84 (17.8)
Systolic blood pressure, mmHg (n = 210/249) 146 [128–165]
Number of drugs 7 [5–9]
≥ 5 drugs per day 382 (80.0)
Minnesota Living with Heart Failure
Questionnaire (n = 100/102)
< 24 (good quality of life) 54 (26.7)
[24–45] (intermediate quality of life) 97 (48.0)
> 45 (poor quality of life) 51 (25.2)
Laboratory parameters at admission
Sodium, mmol/L (n = 282/188) 138 [135–141]
Haemoglobin, g/dL (n = 212/247) 12.3 (11.1–13.6)
Creatinine clearance, mL/minuteb (n = 218/250)
≥ 60 213 (45.5)
]30–60[ 196 (41.9)
≤ 30 59 (12.6)
Nutritional parameters
Body mass index, Kg/m2 (n = 146/166)
< 19 10 (3.2)
[19–21 [ 18 (5.8)
[21–23 [ 39 (12.5)
≥ 23 245 (78.5)
MNA-SF score (n = 69/81)
≥ 12 (well-nourished) 58 (38.7)
[8–12] (at risk) 73 (48.7)
< 8 (malnourished) 19 (12.7)
Recent weight loss >3 Kg (<3 months) (n = 201/226) 64 (15.0)
Table 1 Baseline characteristics of elderly patients admitted for
acute decompensated heart failure (Continued)




Number of impaired ADL items (n = 201/226) 2 [0–5]
ADL score <12, (n = 201/226) 268 (62.8)
Timed get-up-and-go >20 sc, (n = 178/210) 296 (76.2)
Cognition
MMSE ≤17, severe impairment (n = 221/251) 97 (20.6)
Depression
GDS score ≥5 (n = 143/148) 142 (48.8)
Quantitative variables are expressed as median [25th - 75th centiles] and
categorical variables as N (%)
(n= /) indicates the number of patients in each group in case of missing data
MNA-SF, Mini Nutritional Assessment-Short Form; ADL, activities of daily living
scale; MMSE, Mini Mental State Examination; GDS, Geriatric Depression Scale
aHypertension was defined as blood pressure ≥140/90 mmHg or treatment
for hypertension
bCreatinine clearance was calculated using the abbreviated Modification of
Diet in Renal Disease formula, glomerular filtration rate (mL/min/1.73 m2) =
186.3 × [creatinine (μmol/L) /88.4] -1.154 × [Age (years)]-0.203 × 0.742 (if female) ×
1.21 (if black)
cTimed Get-Up-and-Go test >20 s or patient unable to perform the test
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systolic blood pressure at admission, and recent weight
loss. A trend was observed for renal failure.
One-year mortality rates close to 40% have been re-
ported in subgroups of elderly patients in Canada, the
United States, and Israel [5, 7, 10, 11, 14], in keeping
with the 41.7% rate in our ELISA cohort. Other studies
obtained variable results. In a Scottish study, 1-year
mortality rates were 49% and 56% in the groups aged
75–84 years and >84 years, respectively [4]. In contrast,
several studies from Spain, Canada, the United States,
and Europe (EHFS II survey) found 1-year mortality
rates of about 30% [6, 8, 9, 13]. These discrepancies may
reflect differences in inclusion criteria regarding age,
ADHF versus newly diagnosed HF, and presentation to
the emergency department versus elsewhere. The 2-year
mortality rate of 56% in our study is consistent with pre-
vious reports from Brazil and the United States [17, 18].
Conversely, an Italian study [16] estimated 2-year mor-
tality at 22.9%. This difference may be ascribable to the
younger mean age of 74 years and lesser severity of HF
(NYHA class II).
We identified several admission characteristics that
predicted 2-year mortality in elderly patients admitted
for ADHF. The discrimination level of our final multi-
variable model (Harrell’s c-index, 0.64) suggests an influ-
ence on long-term mortality of additional variables not
evaluated in our study. Indeed, other factors previously
associated with increased mortality in patients with HF,
e.g., type and duration of HF or medical therapy, may
also have affected patient outcomes in our study. Three
of the six parameters independently associated with 1-
year and 2-year mortality, namely, lower systolic blood
pressure, renal failure, and functional impairment before
admission, were also associated with in-hospital mortal-
ity in the ELISA cohort [21].
Several studies previously documented an independent
adverse effect of male sex and older age on mortality in
elderly patients with HF, in keeping with our results [4,
5, 7, 8, 11, 16]. Similarly, lower systolic blood pressure
[9–11, 13, 16–18] and renal dysfunction [9–11] were
also previously associated with mortality.
Few studies have assessed pre-admission functional
impairment as a prognostic marker in elderly patients
with ADHF. The association of this factor with 2-year
mortality in our population is consistent with two stud-
ies assessing associations between findings from a global
geriatric assessment and 1-year mortality [6, 12]. These
two studies and ours produced similar results despite
using different functional assessment tools (Katz ADL,
Barthel index, or instrumental ADL), a fact that supports
the validity of our results. That neither of the two previ-
ous studies found associations of mortality with other
factors, including older age, male sex, systolic blood
pressure, and renal impairment, may be ascribable to
limited statistical power (88 and 162 patients). Further-
more, in the octogenarians of the EHFS II survey, dis-
ability (‘self-care problems’) independently predicted
long-term mortality in the multivariable analysis [9].
Our results are consistent with those of studies in other
clinical settings, in which functional status predicted
mortality independently from the underlying medical
conditions. Interestingly, the 2-year risk of death in our
population increased by 11% for each additional im-
paired ADL item.
Another important finding from our study is the influ-
ence of nutritional status. Not only recent weight loss,
Fig. 2 Kaplan-Meier survival distribution, with 95% confidence intervals, of 478 patients aged 75 years or over and discharged after admission for
acutely decompensated heart failure
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Table 2 Comparison of survivors and non-survivors using age-adjusted Cox proportional hazards regression models
Characteristics Survivors Non-survivors Age-adjusted analysisa P value
n = 224 n = 254 HR [95%CI]
Socio-demographic characteristics
Age >85 years 88 (39.0) 134 (53) 1.49 [1.17–1.91] 0.01
Male sex 63 (28.1) 92 (36.2) 1.32 [1.02–1.72] 0.03
Living arrangements (n = 220/244)
Lives alone 188 (85.5) 198 (81.1) 1
Institutionalised 32 (14.5) 46 (18.9) 1.17 [0.84–1.61] 0.35
Current or former smoker (n = 211/242) 53 (25.1) 57 (23.6) 1.00 [0.74–1.34] 0.99
Medical status
Co-morbidities (past or current):
Arteritis (n = 207/234) 19 (9.2) 34 (14.5) 1.28 [0.89–1.85] 0.18
Myocardial infarction (n = 220/251) 36 (16.4) 61 (24.3) 1.27 [0.95–1.69] 0.11
Stroke (n = 218/245) 20 (9.2) 31 (12.7) 1.29 [0.86–1.83] 0.24
Anaemia (n = 209/233) 44 (21.1) 72 (30.9) 1.34 [1.02–1.77] 0.04
Hypertensionb (n = 223/254) 166 (74.4) 188 (74.0) 0.96 [0.72–1.27] 0.76
Cardiac arrhythmia (n = 215/245) 141 (65.6) 172 (70.2) 1.02 [0.77–1.35] 0.87
Diabetes (n = 218/253) 43 (19.7) 41 (16.2) 0.93 [0.66–1.31] 0.70
Systolic blood pressure, mmHg (n = 210/249)c 150 [135–170] 141 [121–162] 0.83 [0.73–0.96] 0.01
Number of drugs 7 [5–9] 7 [5–9]
≥ 5 drugs per day 171 (76.3) 211 (83.1) 1.26 [0.91–1.75] 0.17
Minnesota Living with Heart Failure Questionnaire (n = 100/102)
< 24 (good quality of life) 29 (29.0) 25 (24.5) 1 0.69
[24–45] (intermediate quality of life) 46 (46.0) 51 (50.0) 1.16 [0.72–1.88]
> 45 (poor quality of life) 25 (25.0) 26 (25.5) 1.27 [0.73–2.21]
Laboratory parameters at admission
Sodium, mmol/L (n = 282/188) 138 [135–141] 138 [135–141] 0.99 [0.97–1.01] 0.43
Haemoglobin, g/dL (n = 212/247) 12.5 [11.3–13.7] 12.1 [10.9–13.4] 0.97 [0.92–1.04] 0.40
Creatinine clearance, mL/minuted (n = 218/250)
≥ 60 117 (53.7) 96 (38.4) 1
[30–60] 83 (38.1) 113 (45.2) 1.28 [0.97–1.68] 0.08
≤ 30 18 (8.3) 41 (16.4) 1.81 [1.25–2.61] <0.01
Nutritional parameters
Body mass index, Kg/m2 (n = 146/166)
< 19 2 (1.4 8 (4.8) 2.30 [1.11–4.74] 0.03
[19–21[ 5 (3.4) 13 (7.8) 1.50 [0.84–2.67] 0.19
[21–23[ 14 (9.6) 25 (15.1) 1.50 [0.98–2.31] 0.08
≥ 23 125 (85.6) 120 (72.3) 1
MNA-SF score (n = 69/81)
≥ 12 (well-nourished) 33 (47.8) 25 (30.9) 1
[8–12[(at risk) 31 (44.9) 42 (51.9) 1.64 [0.99–2.70] 0.05
< 8 (malnourished) 5 (7.2) 14 (17.3) 3.01 [1.52–5.97] <0.01
Recent weight loss >3 Kg (<3 months) (n = 201/226) 22 (10.9) 42 (18.6) 1.59 [1.22–2.06] <0.01
Non-solid nutrition (blended or minced) (n = 215/238) 31 (14.4) 51 (21.4) 1.60 [0.94–1.76] 0.11
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but also malnutrition or risk of malnutrition, predicted
mortality independently from age. The only previous
study assessing the prognostic value of MNA results in
elderly patients with HF found no association with mor-
tality [6]. However, in older adults, malnutrition is often
related to adverse health outcomes and strongly predicts
mortality [40, 41]. Weight loss is common in end-stage
HF and may reflect numerous mechanisms including
neurohormonal dysregulation and an imbalance between
anabolism and catabolism [42]. Our results show that re-
cent weight loss is a major prognostic marker in elderly
patients successfully treated for an episode of ADHF.
Two of the six factors independently associated with
mortality are recognized indicators of fragility. Thus,
recent weight loss is part of the Fried phenotype, and
functional impairment is related to the slowness and low
physical activity criteria [43]. Furthermore, impairment
of one ADL item corresponds to the 6th and 7th cat-
egories of the Canadian Study of Health and Aging
frailty scale [44]. Frailty assessed using both a frailty
index and the Fried phenotype predicted mortality
among community-dwelling patients with HF (mean
age, 71 years) [45]. These results suggest that elderly
patients with HF may require a specific functional and
nutritional evaluation to allow the development of a cus-
tomised treatment plan aimed at improving outcomes. A
number of measures might prove useful. For example,
studies in chronic HF showed that exercise training pro-
duced statistically significant improvements in self-
reported health status among both younger adults [46]
and elderly individuals [47], although mortality was not
significantly affected. Furthermore, the programmes
for elderly patients focused mainly on aerobic and re-
sistance training and did not include a routine assess-
ment of nutritional and functional status [47]. The
cost-effectiveness of a multidisciplinary disease man-
agement programme has been evaluated in elderly
outpatients with HF and mild-to-moderate frailty [48].
Interventional studies might be useful to assess whether
similar programmes decrease mortality and/or improve
function and quality of life of elderly patients discharged
after an ADHF episode.
In a previous study, cognitive impairment was associated
with higher long-term mortality in elderly patients with
chronic HF, but no multivariable analysis was reported [49].
In our cohort, a crude association was observed, but only a
trend towards an association persisted in the age-adjusted
analysis and there was no significant association by multi-
variable analysis. Other prognostic factors in elderly pa-
tients with ADHF have been reported [4, 5, 7, 9–11, 17].
Table 2 Comparison of survivors and non-survivors using age-adjusted Cox proportional hazards regression models (Continued)
Function and mobility
Number of impaired ADL items (n = 201/226)e 1 [0–4] 2 [0–5] 1.10 [1.05–1.17] <0.01
ADL score <12, (n = 201/226) 106 (52.7) 162 (71.7) 1.61 [1.20–2.16] <0.01
Timed get-up-and-go >20 sf, (n = 178/210) 125 (70.2) 171 (81.4) 1.49 [1.05–2.11] 0.03
Cognition
MMSE ≤17, severe impairment (n = 221/251) 38 (17.2) 59 (23.5) 1.26 [0.94–1.69] 0.12
Depression
GDS score ≤5 (n = 143/148) 71 (49.7) 71 (48.0) 0.96 [0.70–1.33] 0.81
HR, hazards ratio; CI, confidence interval; MNA-SF, Mini Nutritional Assessment-Short Form; ADL, activities of daily living scale; MMSE, Mini Mental State
Examination; GDS, Geriatric Depression Scale
aHazards ratios and confidence intervals were estimated using Cox proportional models adjusted for age (≤85 years versus >85 years)
bHypertension was defined as blood pressure ≥140/90 mmHg or treatment for hypertension
cHazards ratios and confidence intervals per increase by 1 standard deviation
dCreatinine clearance was calculated using the abbreviated Modification of Diet in Renal Disease formula, glomerular filtration rate (mL/min/1.73 m2) =
186.3 × [creatinine (μmol/L) /88.4] -1.154 × [Age (years)]-0.203 × 0.742 (if female) × 1.21 (if black)
eHazards ratios and confidence intervals per each additional impaired ADL item
fTimed Get-Up-and-Go test >20 s or patient unable to perform the test
Fig. 3 Kaplan-Meier survival distributions according to age
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We found no significant associations with long-term mor-
tality for other factors, such as diabetes, myocardial infarc-
tion, stroke, and hyponatremia. These results may be
related to the inclusion of functional impairment in our
multivariable model and to differences in inclusion criteria
across studies.
Strength and limitations
The inclusion in a vast multicentre cohort of unse-
lected elderly patients with successful in-hospital
treatment for ADHF and the low lost-to-follow-up
rate over 2 years (7.5%) support the validity of our re-
sults. Furthermore, the inclusion of consecutive pa-
tients limited the risk of selection bias, and the main
endpoint (overall mortality) is a robust criterion that
leaves little room for classification bias. Finally, we
routinely adjusted all analyses for age as a potential
confounder, and we took interactions and confounding
into account in the analyses. The similar HR values
obtained after bootstrapping resampling procedures
further support the robustness of our findings. More-
over, few data exist on long-term outcomes of patients
older than 75 years after successful inhospital ADHF
management. A limitation of our study is the absence
in the analysis of several factors having previously
reported associations with increased mortality, such
as, ventricular function, BNP or NT-proBNP concen-
tration, and treatments. Several studies suggest that a
score including NT-proBNP may predict post-discharge
1-year mortality in ADHF populations with a mean age of
about 60-75 years; therefore, in our population of very
elderly patients, using this score to adjust the fragility
indicators associated with post-discharge mortality
would have been of interest [15]. However, our findings
demonstrate the prognostic value of geriatric characteris-
tics in elderly patients with ADHF.
Conclusion
Independent predictors of 2-year mortality in unselected
elderly patients discharged after inhospital treatment for
ADHF included not only older age, male sex, lower systolic
blood pressure, and lower creatinine clearance; but also
geriatric markers of frailty, such as functional impairment
and recent weight loss. An assessment of frailty should
therefore be considered an integral part of the evaluation
of elderly patients admitted for ADHF. For this frail popu-
lation, an interdisciplinary approach targeting the multidi-
mensional aspects of health may improve outcomes.
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